Linde plc (LIN) | The Buildout — AI Infrastructure

The Verdict

Linde produces and delivers industrial gases — oxygen, nitrogen, argon, hydrogen and specialty gases — that manufacturers consume at scale. Its on-site model builds a plant at a customer's fence line and charges for the molecules under long-term contract. That makes it an embedded supplier to advanced semiconductor fabs, which need ultra-high-purity gases in enormous volumes and cannot easily switch providers. Linde also designs and builds the air separation and hydrogen plants themselves, so winning the equipment often leads to years of gas sales afterward.

Earnings Beat

Linde reported Q2 2026 sales of $9,289 million, up 9% year over year and 6% sequentially, including a 2% currency tailwind. Operating margin was 29.5%, down 60 basis points year over year, or 30 basis points excluding cost pass-through, with the U.S. homecare business named as the majority driver. Adjusted earnings per share were $4.50, up 10%. The standout was the sale-of-gas backlog, which rose $1 billion to a record $8.1 billion after a U.S. electronics win.

Management tone: Management's tone shifted on margins between the two calls in the source window. On the May 2026 call the CFO described full-year margin expansion at the 'upper end or even above' a 40-to-60 basis-point range. On the July 2026 call the CEO opened and answered most of the questions and said the company was 'not satisfied' with its margin performance. The electronics wins and the backlog '8 handle' that the May call described as likely were delivered inside one quarter. The OCI Woodside hydrogen startup slipped to Q1 2027 and was not mentioned on the July call.

Management Guidance

For Q3 2026, management guided EPS to $4.45-$4.55, or 6-8% growth, assuming no currency impact year over year but a 1% FX headwind sequentially. For full-year 2026, management raised the bottom of its EPS range to $17.70-$17.90, or 8-9% growth excluding a 1% FX tailwind assumption, leaving the top unchanged. Both ranges assume no economic improvement at the midpoint, and base-volume recovery is deliberately not embedded until management has 'a few more quarters under our belt.' Helium assumptions were held, with any volume or price improvement treated as upside rather than baked in. Management reaffirmed its 8-12% medium-term EPS algorithm.

Trajectory

Revenue has accelerated. After three roughly flat sequential quarters — $8,615 million, $8,764 million and $8,781 million — Q2 2026 sales rose 6% sequentially to $9,289 million and 9% year over year, with about 4% of that underlying after currency and acquisitions. The mix is rotating toward contracted on-site supply and electronics, and the sale-of-gas backlog rose $1 billion to a record $8.1 billion. Margins are the soft spot: the company's reported operating margin of 29.5% was down 60 basis points year over year, with the U.S. homecare business the majority driver. On reported figures, the EBITDA margin has held steady quarter to quarter and free cash flow converted at 68% of net income over the trailing twelve months.

The Model

The model projects FY+1 revenue of $36,750 million and EBITDA of $14,112 million, a 38.4% margin, and FY+2 revenue of $39,250 million and EBITDA of $15,229 million, a 38.8% margin. The near-term anchor is the contracted pipeline: the $8.1 billion sale-of-gas backlog, more than 20 project startups worth about $1.3 billion in the remainder of 2026, and the $1 billion Phoenix award. The FY+2 step-up depends on those projects ramping toward full capacity utilization and on electronics staying the fastest-growing end market. Neither year assumes helium improvement, which management has excluded from its own guidance.

Projections are the median of 5 independent model runs. The model’s revenue sits 4.5% above analyst consensus.

For Q3 2026, management guided EPS to $4.45-$4.55, or 6-8% growth, assuming no currency impact year over year but a 1% FX headwind sequentially. For full-year 2026, management raised the bottom of its EPS range to $17.70-$17.90, or 8-9% growth excluding a 1% FX tailwind assumption, leaving the top unchanged. Both ranges assume no economic improvement at the midpoint, and base-volume recovery is deliberately not embedded until management has 'a few more quarters under our belt.' Helium assumptions were held, with any volume or price improvement treated as upside rather than baked in. Management reaffirmed its 8-12% medium-term EPS algorithm.

What Could Go Right — and Wrong

Looking Ahead

Over the next twelve months the visible milestones are the year-end 2026 sale-of-gas backlog, which management expects to hold an '8 handle' even after about $1.3 billion of project startups, and the Q3 2026 margin print, which management says it expects to improve sequentially. The cost actions promised for the October call and the U.S. homecare strategic review are the two levers that would move the margin story. Further out, FY2027 guidance detail is deferred to 'later in the year… early next year,' the OCI Woodside ATR and sequestration startup is now set for Q1 2027, and helium normalization is expected in early 2027.

Financials

Annual Summary

Key Ratios (Trailing)

The Company

Linde produces atmospheric gases — oxygen, nitrogen, argon and the rare gases — and process gases including hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases and specialty gases. Its 10-K describes it as 'the largest industrial gas company worldwide and a major technological innovator in the industrial gases industry.' It also designs and builds the equipment that produces industrial gases and offers gas production and processing services. These gases are largely consumed as they are produced, shipped by pipeline, bulk delivery or packaged delivery, and the on-site model places a plant at a customer's fence line under long-term contract. Revenue for Q1 2026 split across merchant (29%), on-site (25%), packaged gas (35%) and other (11%).

The company runs four reporting segments: Americas, EMEA, APAC and Engineering. It is a capital-intensive, physically embedded network — plants and pipeline complexes built close to customers, with long-lived assets and long-dated contracts. The 10-K counts five major North American pipeline complexes, at northern Indiana, Houston, the Gulf Coast of Texas, Detroit and Louisiana, and four owned Engineering component factories in Tacherting, Germany; Hesingue, France; New York; and Dalian, China.

Business Segments

Competitive Landscape

The industrial gas market is an oligopoly at the top and fragmented underneath. Linde's 10-K names its competitors as 'L'Air Liquide S.A., Air Products and Chemicals, Inc., Messer Group GmbH, Mitsubishi Chemical Holdings Corporation (through Taiyo Nippon Sanso Corporation)' plus 'an extensive number of small to medium size independent industrial gas companies which compete locally as producers or distributors.' A peer filing cited in the source frames the top of the market as three global players — Air Liquide, Linde and Messer. Competition is regional and relationship-driven, with long-term on-site contracts at the customer's fence line.

Supply Chain

Linde sits inside the semiconductor materials layer, supplying ultra-high-purity gases and the on-site plants that produce them. Its 10-K discloses no sole-source suppliers, and only two supply-chain relationships in the source carry a documented company quote.